State-of-the-Art Innovation Center Opens in Mumbai
MUMBAI, India--(BUSINESS WIRE)--Jan. 23, 2014--
Further developing its capabilities in a key emerging market, Covidien
(NYSE:COV) has officially opened its first training and education center
in India. The Covidien Center of Innovation India (CCI India), located
in Mumbai, offers clinicians training on advanced procedures and
techniques using leading equipment and technology.
“This center is designed to enhance physician capabilities in a way that
meets the unique needs of the local market, ultimately giving patients
in India greater access to advanced procedures and care,” said Brian D.
King, President, Emerging Markets, Covidien. “Expanding our training and
education capabilities worldwide is a key component of Covidien’s global
growth strategy and this new center in Mumbai will play an integral role
as we continue to focus on important emerging geographies.”
CCI India will focus on raising awareness of various disease states and
providing opportunities for clinicians to see how Covidien’s devices can
help healthcare professionals treat these diseases. The top three
priorities will be procedures to address vascular disease, metabolic
disorders (obesity and Type II diabetes) and cancer.
Mark Rooney, Managing Director, India Subcontinent, Covidien, said,
“Chronic diseases contribute to over half of Indian deaths.
Cardiovascular disease, dyslipidemia and many types of cancers are
highly prevalent in urban and rural areas alike1,2. Many of
these diseases, although common, are inadequately diagnosed and treated.
At CCI India, we will focus on innovative procedures and disease
management that address many of India’s most challenging disease states.”
The CCI India is Covidien’s third training center in an emerging market,
with other centers located in Shanghai, China, and Osong, South Korea.
The company plans to open additional centers this year in Istanbul,
Turkey, and São Paulo, Brazil.
Integrating a wide range of industry-leading Covidien surgical devices
and medical equipment, CCI India offers:
A surgical lab with seven fully-equipped operating stations
A simulation lab for clinical scenario training with a human patient
A library stocked with the latest medical journals and four
An auditorium with seating capacity for 60 people and an optimized
multimedia system to provide an immersive and experiential training
Key opinion and industry leaders will train and assist physicians, as
well as supervise them in their individual procedures in a hospital
setting after their training at CCI India. The center will have the
capacity to train more than 5,000 healthcare professionals annually,
both those from within India and those travelling from the surrounding
According to Hon. Dr. Pravin H. Shingare, Director, Directorate of
Medical Education and Research, Government of Maharashtra, “The
Department of Medical Education, Government of Maharashtra is committed
to high quality medical education that improves medical services for the
general public. We welcome the opening of the CCI India in Maharashtra
and congratulate Covidien on its endeavor to supplement the
infrastructure for medical training of professionals in the state.”
Covidien has an important and growing presence in India with offices in
Gurgaon, Mumbai, Chennai, Kolkata and Hyderabad. The company has more
than 400 employees in India with a strong network of distributors and
partner hospitals across the country. In 2012, Covidien opened an R&D
center, Covidien India Engineering Center, in Hyderabad.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien develops,
manufactures and sells a diverse range of industry-leading medical
device and supply products. With 2013 revenue of $10.2 billion, Covidien
has more than 38,000 employees worldwide in more than 70 countries, and
its products are sold in over 150 countries. Please visit www.covidien.com
to learn more about our business.
1 World Health Organization, 2010 study, http://www.who.int/nmh/countries/ind_en.pdf
2 Oxford Journals, 2006 Report, http://ije.oxfordjournals.org/content/35/6/1522.full
Lisa Clemence, 508-452-4375
Lannum, CFA, 508-452-4343